Moderna shares fall after FDA refuses to overview influenza vaccine software
The US Meals and Drug Administration has declined to overview Moderna’s approval software for its novel mRNA flu vaccine, inflicting a fall within the firm’s shares on late Tuesday. Moderna on Tuesday stated in a press release that the FDA had declined the applying saying that its research didn’t examine the experimental shot to the … Read more